Close X
Attorney Spotlight

What colorful method does Claire Miley use to keep up with the latest healthcare regulations as they relate to proposed transactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

CLARCOR
Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Securities Law Exchange BlogSecurities Law Exchange blog offers insight on the latest legal and regulatory developments affecting publicly traded companies. It focuses on a wide variety of topics including regulation and reporting updates, public company advisory topics, IPO readiness and exchange updates including IPO announcements, M&A trends and deal news.

Read More >

Eric J. Knox

Associate

Nashville
(615) 742-7807 TEL
(615) 248-8806 FAX

Eric J. Knox

Associate

Nashville
(615) 742-7807 TEL
(615) 248-8806 FAX
Nashville
(615) 742-7807 TEL
(615) 248-8806 FAX

Working with both national and local companies in the REIT, financial, healthcare, restaurant, food production, hospitality and petroleum refining and transportation sectors, Eric Knox routinely counsels public and private companies on a variety of corporate and securities issues.

Working with both national and local companies in the REIT, financial, healthcare, restaurant, food production, hospitality and petroleum refining and transportation sectors, Eric Knox routinely counsels public and private companies on a variety of corporate and securities issues.

Eric's practice involves:

  • Mergers & Acquisitions – Representing public and private companies on a wide variety of transactions.
  • Corporate Finance – Assisting clients in connection with public offerings, Rule 144A offerings and private placements.
  • Corporate Governance – Advising public company clients on preparation of Form 10-Ks, 10-Qs, 8-Ks, proxy statements and earnings releases; compliance with federal securities laws requirements; compliance with stock exchange listing standards and corporate governance guidelines.
  • Shareholder Activism – Advising clients on issues, including takeover defense, proxy contests, responding to shareholder proposals and related corporate governance and securities law matters, as well as assisting clients with respect to shareholder rights plans, contested director elections, classified boards, advance notice bylaws, Rule 14a-8 shareholder proposals, ISS and other proxy advisory firm-related matters and Section 13 of the Securities Exchange Act.

+ Read More

- Read Less

Memberships

American Bar Association

American Health Lawyers Association (AHLA)

News

View More

Representative Experience

View More

Publications

View More

Media Mentions

View More

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.